About the Practice
My work has always lived at the intersection of science and human connection. I am both a clinician and a researcher, and I bring the strengths of each role directly into care. My research in cancer survivorship focuses on identifying biomarkers for treatment‑related symptoms, designing protocols, and developing individualized treatment plans. My clinical work centers on helping individuals, couples, and families navigate emotional, relational, and cognitive challenges.
I believe people deserve access to emerging tools long before they become mainstream. That’s why I integrate neuroscience‑based approaches — including neuromodulation — into both survivorship care and mental health treatment when appropriate. My goal is to provide care that is evidence‑based, relational, and tailored to your goals.
Our Approach
-
Research‑informed care delivered in real time
-
Integrated neuromodulation + psychotherapy when clinically appropriate
-
Clear, individualized treatment planning
-
Warm, grounded, patient‑centered support
-
A focus on clarity, resilience, and meaningful change
Who We Work With
-
Cancer survivors navigating life after treatment
-
Individuals seeking personal growth or emotional support
-
Couples and families working through relational challenges
Why Was Neuromod Labs Founded?
Advances in neuroscience are moving faster than ever, discovering new ways to ease the symptoms that affect millions of people living with the effects of cancer and other medical conditions. My lab was the first in the nation to bring neurofeedback technology to cancer survivorship. We have discovered neurofeedback therapies that show clear benefits for cancer survivors—reducing neuropathy, pain, fatigue, cognitive fog, and other treatment‑related symptoms.
However, scientific progress alone is not enough. Despite strong evidence supporting these therapies, most patients wait years—sometimes decades—before they become part of routine care. This delay is especially challenging for cancer survivors, who frequently live with persistent symptoms long after treatment ends.
Our Initiative was created to change that timeline. We bring together scientific discovery, clinical innovation, and real‑world implementation to ensure that proven neurofeedback therapies reach the individuals, families, and communities who need them most.
Content reviewed by: Dr Sarah Prinsloo, PhD
Last Updated: 14 October 2026